In the last 12 months, insiders at Marker Therapeutics, Inc. ($MRKR) filed 14 transactions with the SEC: 2 open-market purchases totaling $1,809,072 and 0 sales totaling $0. Net insider sentiment: net buying.
Marker Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- New Enterprise Associates 16, L.P. (Not found) — 1 transaction totaling $1,773,600
- ELMS STEVE (Director) — 4 transactions totaling $35,472
- Eansor Norman David (Director) — 3 transactions totaling $0
- Corzo Kathryn Penkus (Director) — 1 transaction totaling $0
- Knobil Katharine (Director) — 3 transactions totaling $0
View all SEC Filings for Marker Therapeutics, Inc. (MRKR).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 17, 2025 | ELMS STEVE | Director | A | Stock Option (right to buy) | 137330 | $0.00 | 137,330.0000 | 16,757,678 | 9999.99% | 0.82% |
| Nov. 17, 2025 | Knobil Katharine | Director | A | Stock Option (Right to Buy) | 84411 | $0.00 | 84,411.0000 | 16,757,678 | 9999.99% | 0.50% |
| Nov. 17, 2025 | ELMS STEVE | Director | A | Stock Option (right to buy) | 84411 | $0.00 | 84,411.0000 | 16,757,678 | 9999.99% | 0.50% |
| Nov. 17, 2025 | Eansor Norman David | Director | A | Stock Option (Right to Buy) | 137330 | $0.00 | 137,330.0000 | 16,757,678 | 9999.99% | 0.82% |
| Nov. 17, 2025 | Eansor Norman David | Director | A | Stock Option (Right to Buy) | 84411 | $0.00 | 84,411.0000 | 16,757,678 | 9999.99% | 0.50% |
| Nov. 17, 2025 | Knobil Katharine | Director | A | Stock Option (Right to Buy) | 137330 | $0.00 | 137,330.0000 | 16,757,678 | 9999.99% | 0.82% |
| Oct. 31, 2025 | Vera Juan | Chief Executive Officer | A | Employee Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 16,757,678 | 9999.99% | 1.49% |
| Oct. 31, 2025 | Corzo Kathryn Penkus | Director | A | Stock Option (Right to Buy) | 147611 | $0.00 | 147,611.0000 | 16,757,678 | 9999.99% | 0.88% |
| Feb. 12, 2025 | ELMS STEVE | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,980,207 | 9999.99% | 0.33% |
| Feb. 12, 2025 | Vera Juan | President and CEO | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 8,980,207 | 9999.99% | 0.56% |
| Feb. 12, 2025 | Eansor Norman David | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,980,207 | 9999.99% | 0.33% |
| Feb. 12, 2025 | Knobil Katharine | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 8,980,207 | 9999.99% | 0.33% |
| Dec. 23, 2024 | ELMS STEVE | Director | P | Common Stock | 11085 | $3.20 | 328,338.0000 | 8,923,170 | 3.49% | 0.12% |
| Dec. 23, 2024 | New Enterprise Associates 16, L.P. | Not found | P | Common Stock | 554250 | $3.20 | 1,625,678.0000 | 8,923,170 | 51.73% | 6.21% |